Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.68 USD | +2.34% | -5.18% | +16.16% |
May. 17 | Oppenheimer Initiates Capricor Therapeutics at Outperform Rating | MT |
May. 13 | Transcript : Capricor Therapeutics, Inc., Q1 2024 Earnings Call, May 13, 2024 |
Turnover - Change in analysts' estimates
Earnings Per Share (EPS) - Change in analysts' estimates
EBIT - Change in analysts' estimates
Turnover
Earnings Per Share (EPS)
EBIT
- Stock Market
- Equities
- CAPR Stock
- Revisions Capricor Therapeutics, Inc.